Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors

Molecular Aspects of Medicine

Volumn 58, Issue , 2017, Pages 114-129

  Chiang, Nan ^a   Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Inflammation; Leukocytes; maresins; Omega 3 PUFA; protectins; Resolvins

Indexed keywords

17 EPI REOLVIN D1; ARACHIDONIC ACID; CD59 ANTIGEN; CHEMICAL COMPOUND; CHEMICAL MEDIATOR; G PROTEIN COUPLED RECEPTOR; LIPOXIN; LIPOXIN A; MARESIN; OMEGA 3 FATTY ACID; PLACEBO; RESOLVIN; RESOLVIN D1; RESOLVIN D2; RESOLVIN E1 DERIVATIVE; SPECIALIZED PRO RESOLVING MEDIATOR; UNCLASSIFIED DRUG; AUTACOID;

HUMAN; INFECTION; INFLAMMATION; NONHUMAN; PAIN; PATHOGEN CLEARANCE; REVIEW; TISSUE REGENERATION; ANIMAL; CHEMISTRY; CLINICAL TRIAL (TOPIC); DISEASE MODEL; HOST PATHOGEN INTERACTION; LIPID METABOLISM; METABOLISM; PATHOLOGY; PHYSIOLOGY; REGENERATION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TREATMENT OUTCOME;

ANIMALS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; HOST-PATHOGEN INTERACTIONS; HUMANS; INFECTION; INFLAMMATION; INFLAMMATION MEDIATORS; LIPID METABOLISM; REGENERATION; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TREATMENT OUTCOME;

EID: 85016415190     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2017.03.005     Document Type: Review

References (192)

1. Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C.N., Sher, A., Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 3 (2002), 76–82.
2. Aliberti, J., Serhan, C., Sher, A., Parasite-induced lipoxin A(4) is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 196 (2002), 1253–1262.
3. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N.A., Serhan, C.N., Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201 (2005), 713–722.
4. 4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 178 (2007), 3912–3917.
5. Arnardottir, H., Orr, S.K., Dalli, J., Serhan, C.N., Human milk proresolving mediators stimulate resolution of acute inflammation. Mucosal Immunol. 9 (2016), 757–766.
6. Arnardottir, H.H., Dalli, J., Colas, R.A., Shinohara, M., Serhan, C.N., Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines. J. Immunol. 193:8 (2014), 4235–4244.
7. Arnardottir, H.H., Dalli, J., Norling, L.V., Colas, R.A., Perretti, M., Serhan, C.N., Resolvin D3 is dysregulated in arthritis and reduces arthritic inflammation. J. Immunol. 197:6 (2016), 2362–2368.
8. Aursnes, M., Tungen, J.E., Colas, R.A., Vlasakov, I., Dalli, J., Serhan, C.N., Hansen, T.V., Synthesis of the 16S,17S-Epoxyprotectin intermediate in the biosynthesis of protectins by human macrophages. J. Nat. Prod. 78 (2015), 2924–2931.
9. Bafica, A., Scanga, C.A., Serhan, C., Machado, F., White, S., Sher, A., Aliberti, J., Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J. Clin. Invest. 115 (2005), 1601–1606.
10. Bannenberg, G.L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K.H., Hong, S., Serhan, C.N., Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174 (2005), 4345–4355.
11. Barden, A.E., Mas, E., Mori, T.A., n-3 Fatty acid supplementation and proresolving mediators of inflammation. Curr. Opin. Lipidol. 27:1 (2016), 26–32.
12. Barden, A.E., Moghaddami, M., Mas, E., Phillips, M., Cleland, L.G., Mori, T.A., Specialised pro-resolving mediators of inflammation in inflammatory arthritis. Prostaglandins Leukot. Essent. Fat. Acids 107 (2016), 24–29.
13. Basil, M.C., Levy, B.D., Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat. Rev. Immunol. 16:1 (2016), 51–67.
14. Biteman, B., Hassan, I.R., Walker, E., Leedom, A.J., Dunn, M., Seta, F., Laniado-Schwartzman, M., Gronert, K., Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J. 21 (2007), 2257–2266.
15. Borgeson, E., Godson, C., Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications. Front. Immunol., 3, 2012, 318.
16. Börgeson, E., McGillicuddy, F.C., Harford, K.A., Corrigan, N., Higgins, D.F., Maderna, P., Roche, H.M., Godson, C., Lipoxin A4 attenuates adipose inflammation. FASEB J. 26:10 (2012), 4287–4294.
17. Bouatra, S., Aziat, F., Mandal, R., Guo, A.C., Wilson, M.R., Knox, C., Bjorndahl, T.C., Krishnamurthy, R., Saleem, F., Liu, P., Dame, Z.T., Poelzer, J., Huynh, J., Yallou, F.S., Psychogios, N., Dong, E., Bogumil, R., Roehring, C., Wishart, D.S., The human urine metabolome. PLoS One, 8(9), 2013, e73076.
18. Bracco, U., Deckelbaum, R.J., Polyunsaturated Fatty Acids in Human Nutrition. 1992, Raven Press, New York.
19. Brancaleone, V., Gobbetti, T., Cenac, N., le Faoudier, P., Colom, B., Flower, R.J., Vergnolle, N., Nourshargh, S., Perretti, M., A vasculo-protective circuit centred on Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. Blood 122 (2013), 608–617.
20. 4 . Impact of aspirin therapy. Circulation 86 (1992), 56–63.
21. Buckley, C.D., Gilroy, D.W., Serhan, C.N., Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 40:3 (2014), 315–327.
22. Business Wire, 2009. Resolvyx announces positive data from Phase 2 clinical trial of the reesolvin RX-10045 in patients with dry eye syndrome. http://www.businesswire.com/news/home/20090824005320/en/Resolvyx-Announces-Positive-Data-Phase-20090824005322-Clinical.
23. Campbell, E.L., Serhan, C.N., Colgan, S.P., Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators. J. Immunol. 187 (2011), 3475–3481.
24. Chan, M.M.-Y., Moore, A.R., Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J. Immunol. 184 (2010), 6418–6426.
25. Chiang, N., Dalli, J., Colas, R.A., Serhan, C.N., Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J. Exp. Med. 212:8 (2015), 1203–1217.
26. Chiang, N., de la Rosa, X., Libreros, S., Serhan, C.N., Novel resolvin D2 receptor Axis in infectious inflammation. J. Immunol. 198:2 (2017), 842–851.
27. Chiang, N., Fredman, G., Bäckhed, F., Oh, S.F., Vickery, T.W., Schmidt, B.A., Serhan, C.N., Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484 (2012), 524–528.
28. Chiang, N., Schwab, J.M., Fredman, G., Kasuga, K., Gelman, S., Serhan, C.N., Anesthetics impact the resolution of inflammation. PLoS One, 3, 2008, e1879.
29. Chiang, N., Shinohara, M., Dalli, J., Mirakaj, V., Kibi, M., Choi, A.M.K., Serhan, C.N., Inhaled carbon monoxide accelerates resolution of inflammation via unique pro-resolving mediator–heme oxygenase-1 circuits. J. Immunol. 190 (2013), 6378–6388.
30. Chiurchiu, V., Leuti, A., Dalli, J., Jacobsson, A., Battistini, L., Maccarrone, M., Serhan, C.N., Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses. Sci. Transl. Med., 8(353), 2016 353ra111.
31. Cilloniz, C., Pantin-Jackwood, M.J., Ni, C., Goodman, A.G., Peng, X., Proll, S.C., Carter, V.S., Rosenzweig, E.R., Szretter, K.J., Katz, J.M., Korth, M.J., Swayne, D.E., Tumpey, T.M., Katze, M.G., Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. J. Virol. 84:15 (2010), 7613–7624.
32. Colas, R.A., Shinohara, M., Dalli, J., Chiang, N., Serhan, C.N., Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am. J. Physiol. Cell Physiol. 307 (2014), C39–C54.
33. Cooray, S.N., Gobbetti, T., Montero-Melendez, T., McArthur, S., Thompson, D., Clark, A.J., Flower, R.J., Perretti, M., Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc. Natl. Acad. Sci. U. S. A. 110:45 (2013), 18232–18237.
34. Cortina, M.S., Bazan, H.E., Docosahexaenoic acid, protectins and dry eye. Curr. Opin. Clin. Nutr. Metab. Care 14:2 (2011), 132–137.
35. Cotran, R.S., Inflammation: historical perspectives. Gallin, J.I., Snyderman, R., Fearon, D.T., Haynes, B.F., Nathan, C., (eds.) Inflammation: Basic Principles and Clinical Correlates, third ed., 1999, Lippincott Williams & Wilkins, Philadelphia.
36. Dalli, J., Chiang, N., Serhan, C.N., Identification of sulfido-conjugated mediators that promote resolution of infection and organ protection. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E4753–E4761.
37. Dalli, J., Chiang, N., Serhan, C.N., Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections. Nat. Med. 21 (2015), 1071–1075.
38. Dalli, J., Colas, R.A., Arnardottir, H., Serhan, C.N., Vagal regulation of group 3 innate lymphoid cells and the immunoresolvent PCTR1 controls infection resolution. Immunity 46:1 (2017), 92–105.
39. Dalli, J., Colas, R.A., Quintana, C., Barragan-Bradford, D., Hurwitz, S., Levy, B.D., Choi, A.M., Serhan, C.N., Baron, R.M., Human sepsis eicosanoid and proresolving lipid mediator temporal profiles: correlations with survival and clinical outcomes. Crit. Care Med. 45 (2017), 58–68.
40. Dalli, J., Kraft, B.D., Colas, R.A., Shinohara, M., Fredenburgh, L.E., Hess, D.R., Chiang, N., Welty-Wolf, K., Choi, A.M., Piantadosi, C.A., Serhan, C.N., The regulation of proresolving lipid mediator profiles in baboon pneumonia by inhaled carbon monoxide. Am. J. Respir. Cell Mol. Biol. 53:3 (2015), 314–325.
41. Dalli, J., Ramon, S., Norris, P.C., Colas, R.A., Serhan, C.N., Novel proresolving and tissue regenerative resolvin and protectin sulfido-conjugated pathways. FASEB J. 29 (2015), 2120–2136.
42. Dalli, J., Sanger, J.M., Rodriguez, A.R., Chiang, N., Spur, B.W., Serhan, C.N., Identification and actions of a novel third maresin conjugate in tissue regeneration: MCTR3. PLoS One, 11(2), 2016 e0149319.
43. Dalli, J., Serhan, C.N., Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 120 (2012), e60–72.
44. Dalli, J., Vlasakov, I., Riley, I.R., Rodriguez, A.R., Spur, B., Petasis, N.A., Chiang, N., Serhan, C.N., Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 12232–12237.
45. Dalli, J., Winkler, J.W., Colas, R.A., Arnardottir, H., Cheng, C.Y.C., Chiang, N., Petasis, N.A., Serhan, C.N., Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem. Biol. 20 (2013), 188–201.
46. Dalli, J., Zhu, M., Vlasenko, N.A., Deng, B., Haeggstrom, J.Z., Petasis, N.A., Serhan, C.N., The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype. FASEB J. 27 (2013), 2573–2583.
47. Dartt, D.A., Hodges, R.R., Li, D., Shatos, M.A., Lashkari, K., Serhan, C.N., Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J. Immunol. 186:7 (2011), 4455–4466.
48. de Paiva, C.S., Schwartz, C.E., Gjorstrup, P., Pflugfelder, S.C., Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. Cornea 31 (2012), 1299–1303.
49. Delano, M.J., Ward, P.A., Sepsis-induced immune dysfunction: can immune therapies reduce mortality?. J. Clin. Invest. 126:1 (2016), 23–31.
50. Devchand, P.R., Arita, M., Hong, S., Bannenberg, G., Moussignac, R.-L., Gronert, K., Serhan, C.N., Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host-defense. FASEB J. 17 (2003), 652–659.
51. Dinarello, C.A., Anti-inflammatory agents: present and future. Cell 140 (2010), 935–950.
52. Dinarello, C.A., Joosten, L.A., Inflammation in rheumatology in 2015: new tools to tackle inflammatory arthritis. Nat. Rev. Rheumatol. 12:2 (2016), 78–80.
53. El Kebir, D., Gjorstrup, P., Filep, J.G., Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proc. Natl. Acad. Sci. U. S. A. 109:37 (2012), 14983–14988.
54. Elajami, T.K., Colas, R.A., Dalli, J., Chiang, N., Serhan, C.N., Welty, F.K., Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling. FASEB J. 30:8 (2016), 2792–2801.
55. English, J.T., Norris, P.C., Hodges, R.R., Dartt, D.A., Serhan, C.N., Identification and profiling of specialized pro-resolving mediators in human tears by lipid mediator metabolomics. Prostaglandins Leukot. Essent. Fat. Acids 117 (2017), 17–27.
56. Erdinest, N., Ovadia, H., Kormas, R., Solomon, A., Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study. J. Inflamm. (Lond), 11(1), 2014, 6.
57. Felton, J.M., Lucas, C.D., Rossi, A.G., Dransfield, I., Eosinophils in the lung - modulating apoptosis and efferocytosis in airway inflammation. Front. Immunol., 5, 2014, 302.
58. Filep, J.G., Biasing the lipoxin A4/formyl peptide receptor 2 pushes inflammatory resolution. Proc. Natl. Acad. Sci. U. S. A. 110:45 (2013), 18033–18034.
59. Flannigan, K.L., Agbor, T.A., Motta, J.P., Ferraz, J.G., Wang, R., Buret, A.G., Wallace, J.L., Proresolution effects of hydrogen sulfide during colitis are mediated through hypoxia-inducible factor-1alpha. FASEB J. 29:4 (2015), 1591–1602.
60. Frediani, J.K., Jones, D.P., Tukvadze, N., Uppal, K., Sanikidze, E., Kipiani, M., Tran, V.T., Hebbar, G., Walker, D.I., Kempker, R.R., Kurani, S.S., Colas, R.A., Dalli, J., Tangpricha, V., Serhan, C.N., Blumberg, H.M., Ziegler, T.R., Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study. PLoS One, 9(10), 2014, e108854.
61. Fredman, G., Hellmann, J., Proto, J.D., Kuriakose, G., Colas, R.A., Dorweiler, B., Connolly, E.S., Solomon, R., Jones, D.M., Heyer, E.J., Spite, M., Tabas, I., An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nat. Commun., 7, 2016, 12859.
62. Fredman, G., Kamaly, N., Spolitu, S., Milton, J., Ghorpade, D., Chiasson, R., Kuriakose, G., Perretti, M., Farokzhad, O., Tabas, I., Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci. Transl. Med., 7(275), 2015 275ra220.
63. Fullerton, J.N., Gilroy, D.W., Resolution of inflammation: a new therapeutic frontier. Nat. Rev. Drug Discov. 15 (2016), 551–567.
64. Gao, L., Faibish, D., Fredman, G., Herrera, B.S., Chiang, N., Serhan, C.N., Van Dyke, T.E., Gyurko, R., Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. J. Immunol. 190 (2013), 689–694.
65. Gao, Y., Min, K., Zhang, Y., Su, J., Greenwood, M., Gronert, K., Female-specific downregulation of tissue polymorphonuclear neutrophils drives impaired regulatory T cell and amplified effector T cell responses in autoimmune dry eye disease. J. Immunol. 195:7 (2015), 3086–3099.
66. Gilroy, D.W., Lawrence, T., Perretti, M., Rossi, A.G., Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3 (2004), 401–416.
67. Godson, C., Mitchell, S., Harvey, K., Petasis, N.A., Hogg, N., Brady, H.R., Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164 (2000), 1663–1667.
68. Gronert, K., Resolution, the grail for healthy ocular inflammation. Exp. Eye Res. 91:4 (2010), 478–485.
69. Haas-Stapleton, E.H., Lu, Y., Hong, S., Arita, M., Favoreto, S., Nigam, S., Serhan, C.N., Agabian, N., Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator Resolvin E1. PLoS One, 2, 2007, e1316.
70. Harrison, J.L., Rowe, R.K., Ellis, T.W., Yee, N.S., O'Hara, B.F., Adelson, P.D., Lifshitz, J., Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. Brain. Behav. Immun. 47 (2015), 131–140.
71. Hasturk, H., Abdallah, R., Kantarci, A., Nguyen, D., Giordano, N., Hamilton, J., Van Dyke, T.E., Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis. Arterioscler. Thromb. Vasc. Biol. 35:5 (2015), 1123–1133.
72. 4 to promote resolution of allergic airway inflammation. Nat. Immunol. 9 (2008), 873–879.
73. Henson, P.M., Resolution of inflammation. Chest 99 (1991), 2S–6S.
74. Ho, K.J., Spite, M., Owens, C.D., Lancero, H., Kroemer, A.H., Pande, R., Creager, M.A., Serhan, C.N., Conte, M.S., Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am. J. Pathol. 177 (2010), 2116–2123.
75. Hodges, R.R., Li, D., Shatos, M.A., Bair, J.A., Lippestad, M., Serhan, C.N., Dartt, D.A., Lipoxin A4 activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion. Mucosal Immunol, 2016, 10.1038/mi.2016.1033.
76. Hong, S., Gronert, K., Devchand, P., Moussignac, R.-L., Serhan, C.N., Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation. J. Biol. Chem. 278 (2003), 14677–14687.
77. Imai, Y., Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection. Biochim. Biophys. Acta 1851:4 (2015), 496–502.
78. Isobe, Y., Arita, M., Matsueda, S., Iwamoto, R., Fujihara, T., Nakanishi, H., Taguchi, R., Masuda, K., Sasaki, K., Urabe, D., Inoue, M., Arai, H., Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid. J. Biol. Chem. 287:13 (2012), 10525–10534.
79. 4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1. Anesth. Analg. 104 (2007), 369–377.
80. Jones, C.N., Dalli, J., Dimisko, L., Wong, E., Serhan, C.N., Irimia, D., Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 20560–20565.
81. Jones, H.R., Robb, C.T., Perretti, M., Rossi, A.G., The role of neutrophils in inflammation resolution. Semin. Immunol. 28:2 (2016), 137–145.
82. Jones, M.L., Mark, P.J., Keelan, J.A., Barden, A., Mas, E., Mori, T.A., Waddell, B.J., Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta. J. Lipid Res. 54:8 (2013), 2247–2254.
83. Kang, J.W., Lee, S.M., Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis. Biochim. Biophys. Acta 1861:9 Pt A (2016), 1025–1035.
84. Kasuga, K., Yang, R., Porter, T.F., Agrawal, N., Petasis, N.A., Irimia, D., Toner, M., Serhan, C.N., Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J. Immunol. 181 (2008), 8677–8687.
85. Keelan, J.A., Mas, E., D'Vaz, N., Dunstan, J.A., Li, S., Barden, A.E., Mark, P.J., Waddell, B.J., Prescott, S.L., Mori, T.A., Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors. Reproduction 149:2 (2015), 171–178.
86. Koltsida, O., Karamnov, S., Pyrillou, K., Vickery, T., Chairakaki, A.D., Tamvakopoulos, C., Sideras, P., Serhan, C.N., Andreakos, E., Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. EMBO Mol. Med. 5:5 (2013), 762–775.
87. Koopman, W.J., Moreland, L.W., Arthritis and allied conditions: a textbook of rheumatology. fifteenth ed., 2005, Lippincott Williams & Wilkins, Philadelphia.
88. Krishnamoorthy, S., Recchiuti, A., Chiang, N., Fredman, G., Serhan, C.N., Resolvin D1 receptor stereoselectivity and regulation of inflammation and pro-resolving microRNAs. Am. J. Pathol. 180 (2012), 2018–2027.
89. Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C.-H., Yang, R., Petasis, N.A., Serhan, C.N., Resolvin D1 binds human phagocytes with evidence for pro-resolving receptors. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 1660–1665.
90. Kurihara, T., Jones, C.N., Yu, Y.M., Fischman, A.J., Watada, S., Tompkins, R.G., Fagan, S.P., Irimia, D., Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB J. 27 (2013), 2270–2281.
91. Lands, W.E.M., Fish, Omega-3 and Human Health. second ed., 2005, AOCS Press, Champaign, IL.
92. Le Faouder, P., Baillif, V., Spreadbury, I., Motta, J.P., Rousset, P., Chene, G., Guigne, C., Terce, F., Vanner, S., Vergnolle, N., Bertrand-Michel, J., Dubourdeau, M., Cenac, N., LC-MS/MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolites. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 932 (2013), 123–133.
93. Leslie, M., Inflammation's stop signals. Science 347:6217 (2015), 18–21.
94. Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K., Serhan, C.N., Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2 (2001), 612–619.
95. Levy, B.D., Serhan, C.N., Resolution of acute inflammation in the lung. Annu. Rev. Physiol., 76, 2014 27.21-27.26.
96. Li, D., Hodges, R.R., Jiao, J., Carozza, R.B., Shatos, M.A., Chiang, N., Serhan, C.N., Dartt, D.A., Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion. Mucosal Immunol. 6 (2013), 1119–1130.
97. Li, N., He, J., Schwartz, C.E., Gjorstrup, P., Bazan, H.E.P., Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J. Ocul. Pharmacol. Ther. 26 (2010), 431–439.
98. Libby, P., Tabas, I., Fredman, G., Fisher, E.A., Inflammation and its resolution as determinants of acute coronary syndromes. Circ. Res. 114:12 (2014), 1867–1879.
99. Liu, G., Fiala, M., Mizwicki, M.T., Sayre, J., Magpantay, L., Siani, A., Mahanian, M., Chattopadhyay, M., La Cava, A., Wiedau-Pazos, M., Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1. Am. J. Neurodegener. Dis. 1:1 (2012), 60–74.
100. Lucas, C.D., Dorward, D.A., Tait, M.A., Fox, S., Marwick, J.A., Allen, K.C., Robb, C.T., Hirani, N., Haslett, C., Duffin, R., Rossi, A.G., Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung. Mucosal Immunol. 7 (2014), 857–868.
101. Luo, B., Wang, J., Liu, Z., Shen, Z., Shi, R., Liu, Y.Q., Liu, Y., Jiang, M., Wu, Y., Zhang, Z., Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution. Nat. Commun., 7, 2016, 12177.
102. 4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183 (1996), 137–146.
103. Majno, G., The Healing Hand: Man and Wound in the Ancient World. 1975, Harvard University Press, Cambridge.
104. Markworth, J.F., Vella, L.D., Lingard, B.S., Tull, D.L., Rupasinghe, T.W., Sinclair, A.J., Maddipati, K.R., Cameron-Smith, D., Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305 (2013), R1281–R1296.
105. 4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis. J. Immunol. 182 (2009), 5374–5381.
106. Mas, E., Barden, A., Burke, V., Beilin, L.J., Watts, G.F., Huang, R.C., Puddey, I.B., Irish, A.B., Mori, T.A., A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease. Clin. Nutr. 35 (2016), 331–336.
107. Mas, E., Croft, K.D., Zahra, P., Barden, A., Mori, T.A., Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin. Chem. 58 (2012), 1476–1484.
108. Mirakaj, V., Dalli, J., Granja, T., Rosenberger, P., Serhan, C.N., Vagus nerve controls resolution and pro-resolving mediators of inflammation. J. Exp. Med. 211:6 (2014), 1037–1048.
109. Molina-Berrios, A., Campos-Estrada, C., Henriquez, N., Faundez, M., Torres, G., Castillo, C., Escanilla, S., Kemmerling, U., Morello, A., Lopez-Munoz, R.A., Maya, J.D., Protective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A(4)-mediated effect. PLoS Negl. Trop. Dis., 7(4), 2013, e2173.
110. Montanaro, G., Bertinaria, M., Rolando, B., Fruttero, R., Lucas, C.D., Dorward, D.A., Rossi, A.G., Megson, I.L., Gasco, A., Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents. Bioorg. Med. Chem. 21:7 (2013), 2107–2116.
111. Montero-Melendez, T., Gobbetti, T., Cooray, S.N., Jonassen, T.E., Perretti, M., Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects. J. Immunol. 194:7 (2015), 3381–3388.
112. Morita, M., Kuba, K., Ichikawa, A., Nakayama, M., Katahira, J., Iwamoto, R., Watanebe, T., Sakabe, S., Daidoji, T., Nakamura, S., Kadowaki, A., Ohto, T., Nakanishi, H., Taguchi, R., Nakaya, T., Murakami, M., Yoneda, Y., Arai, H., Kawaoka, Y., Penninger, J.M., Arita, M., Imai, Y., The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 153 (2013), 112–125.
113. Morris, T., Stables, M., Colville-Nash, P., Newson, J., Bellingan, G., de Souza, P.M., Gilroy, D.W., Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 8842–8847.
114. Motta, J.P., Flannigan, K.L., Agbor, T.A., Beatty, J.K., Blackler, R.W., Workentine, M.L., Da Silva, G.J., Wang, R., Buret, A.G., Wallace, J.L., Hydrogen sulfide protects from colitis and restores intestinal microbiota biofilm and mucus production. Inflamm. Bowel Dis. 21:5 (2015), 1006–1017.
115. Mozurkewich, E.L., Greenwood, M., Clinton, C., Berman, D., Romero, V., Djuric, Z., Qualls, C., Gronert, K., Pathway markers for pro-resolving lipid mediators in maternal and umbilical cord blood: a secondary analysis of the mothers, Omega-3, and mental health study. Front. Pharmacol., 7, 2016, 274.
116. Mukherjee, P.K., Marcheselli, V.L., Serhan, C.N., Bazan, N.G., Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 8491–8496.
117. Nathan, C., Fresh approaches to anti-infective therapies. Sci. Transl. Med., 4(140), 2012 140sr142.
118. Navarro-Xavier, R.A., Newson, J., Silveira, V.L.F., Farrow, S.N., Gilroy, D.W., Bystrom, J., A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. J. Immunol. 184 (2010), 1516–1525.
119. Norling, L.V., Dalli, J., Flower, R.J., Serhan, C.N., Perretti, M., Resolvin D1 limits polymorphonuclear leukocytes recruitment to inflammatory loci: receptor dependent actions. Arterioscler. Thromb. Vasc. Biol. 32 (2012), 1970–1978.
120. Norling, L.V., Headland, S.E., Dalli, J., Arnardottir, H.H., Haworth, O., Jones, H.R., Irimia, D., Serhan, C.N., Perretti, M., Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis. JCI Insight, 1(5), 2016, e85922.
121. Norling, L.V., Spite, M., Yang, R., Flower, R.J., Perretti, M., Serhan, C.N., Cutting edge: humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. J. Immunol. 186 (2011), 5543–5547.
122. Norris, P.C., Gosselin, D., Reichart, D., Glass, C.K., Dennis, E.A., Phospholipase A2 regulates eicosanoid class switching during inflammasome activation. Proc. Natl. Acad. Sci. U. S. A. 111:35 (2014), 12746–12751.
123. Oh, S.F., Dona, M., Fredman, G., Krishnamoorthy, S., Irimia, D., Serhan, C.N., Resolvin E2 formation and impact in inflammation resolution. J. Immunol. 188 (2012), 4527–4534.
124. Oh, S.F., Pillai, P.S., Recchiuti, A., Yang, R., Serhan, C.N., Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. J. Clin. Invest. 121 (2011), 569–581.
125. Ohira, T., Arita, M., Omori, K., Recchiuti, A., Van Dyke, T.E., Serhan, C.N., Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J. Biol. Chem. 285 (2010), 3451–3461.
126. Orr, S.K., Colas, R.A., Dalli, J., Chiang, N., Serhan, C.N., Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent. Am. J. Physiol. Lung Cell Mol. Physiol. 308:9 (2015), L904–L911.
127. Pascoal, L.B., Bombassaro, B., Ramalho, A.F., Coope, A., Moura, R.F., Correa-da-Silva, F., Ignacio-Souza, L., Razolli, D., de Oliveira, D., Catharino, R., Velloso, L.A., Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity. J. Neuroinflammation, 14(1), 2017, 5.
128. Perretti, M., The resolution of inflammation: new mechanisms in patho-physiology open opportunities for pharmacology. Semin. Immunol. 27:3 (2015), 145–148.
129. Perretti, M., D'Acquisto, F., Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9 (2009), 62–70.
130. Perretti, M., Leroy, X., Bland, E.J., Montero-Melendez, T., Resolution pharmacology: opportunities for therapeutic innovation in inflammation. Trends Pharmacol. Sci. 36:11 (2015), 737–755.
131. Petri, M.H., Laguna-Fernandez, A., Arnardottir, H., Wheelock, C.E., Perretti, M., Hansson, G.K., Back, M., Aspirin-triggered lipoxin inhibits atherosclerosis progression in ApoE-/- mice. Br. J. Pharmacol., Jan 10, 2017, 10.1111/bph.13707.
132. Pierdomenico, A.M., Recchiuti, A., Simiele, F., Codagnone, M., Mari, V.C., Davi, G., Romano, M., MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages. J. Biol. Chem. 290:6 (2015), 3592–3600.
133. Polus, A., Zapala, B., Razny, U., Gielicz, A., Kiec-Wilk, B., Malczewska-Malec, M., Sanak, M., Childs, C.E., Calder, P.C., Dembinska-Kiec, A., Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production. Biochim. Biophys. Acta 1861:11 (2016), 1746–1755.
134. Qiu, W., Guo, K., Yi, L., Gong, Y., Huang, L., Zhong, W., Resolvin E1 reduces hepatic fibrosis in mice with infection. Exp. Ther. Med. 7:6 (2014), 1481–1485.
135. Qu, X., Zhang, X., Yao, J., Song, J., Nikolic-Paterson, D.J., Li, J., Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. J. Pathol. 228 (2012), 506–519.
136. Rajasagi, N.K., Reddy, P.B.J., Suryawanshi, A., Mulik, S., Gjorstrup, P., Rouse, B.T., Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J. Immunol. 186 (2011), 1735–1746.
137. Ramon, S., Dalli, J., Sanger, J.M., Winkler, J.W., Aursnes, M., Tungen, J.E., Hansen, T.V., Serhan, C.N., The Protectin PCTR1 is produced by human M2 macrophages and enhances resolution of infectious inflammation. Am. J. Pathol. 186 (2016), 962–973.
138. Ramon, S., Gao, F., Serhan, C.N., Phipps, R.P., Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells. J. Immunol. 189:2 (2012), 1036–1042.
139. Rao, N.L., Dunford, P.J., Xue, X., Jiang, X., Lundeen, K.A., Coles, F., Riley, J.P., Williams, K.N., Grice, C.A., Edwards, J.P., Karlsson, L., Fourie, A.M., Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. J. Pharmacol. Exp. Ther. 321:3 (2007), 1154–1160.
140. Rathod, K.S., Kapil, V., Velmurugan, S., Khambata, R.S., Siddique, U., Khan, S., Van Eijl, S., Gee, L.C., Bansal, J., Pitrola, K., Shaw, C., D'Acquisto, F., Colas, R.A., Marelli-Berg, F., Dalli, J., Ahluwalia, A., Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. J. Clin. Invest. 127 (2017), 169–182.
141. Recchiuti, A., Codagnone, M., Pierdomenico, A.M., Rossi, C., Mari, V.C., Cianci, E., Simiele, F., Gatta, V., Romano, M., Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. FASEB J. 28:7 (2014), 3090–3102.
142. Recchiuti, A., Krishnamoorthy, S., Fredman, G., Chiang, N., Serhan, C.N., MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. FASEB J. 25 (2011), 544–560.
143. Recchiuti, A., Serhan, C.N., Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation. Front. Immun., 3, 2012, 298.
144. Rius, B., Titos, E., Moran-Salvador, E., Lopez-Vicario, C., Garcia-Alonso, V., Gonzalez-Periz, A., Arroyo, V., Claria, J., Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. FASEB J. 28:2 (2014), 836–848.
145. Robb, C.T., Regan, K.H., Dorward, D.A., Rossi, A.G., Key mechanisms governing resolution of lung inflammation. Semin. Immunopathol. 38:4 (2016), 425–448.
146. Robbins, S.L., Cotran, R., Pathologic basis of disease. second ed., 1979, W.B. Saunders Co., Philadelphia.
147. Rogerio, A.P., Haworth, O., Croze, R., Oh, S.F., Uddin, M., Carlo, T., Pfeffer, M.A., Priluck, R., Serhan, C.N., Levy, B.D., Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J. Immunol. 189:4 (2012), 1983–1991.
148. Russell, C.D., Schwarze, J., The role of pro-resolution lipid mediators in infectious disease. Immunology 141 (2014), 166–173.
149. Samuelsson, B., Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220 (1983), 568–575.
150. Sasaki, A., Fukuda, H., Shiida, N., Tanaka, N., Furugen, A., Ogura, J., Shuto, S., Mano, N., Yamaguchi, H., Determination of omega-6 and omega-3 PUFA metabolites in human urine samples using UPLC/MS/MS. Anal. Bioanal. Chem. 407 (2015), 1625–1639.
151. Savill, J.S., Wyllie, A.H., Henson, J.E., Walport, M.J., Henson, P.M., Haslett, C., Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83 (1989), 865–875.
152. Schwab, J.M., Chiang, N., Arita, M., Serhan, C.N., Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447 (2007), 869–874.
153. Seki, H., Fukunaga, K., Arita, M., Arai, H., Nakanishi, H., Taguchi, R., Miyasho, T., Takamiya, R., Asano, K., Ishizaka, A., Takeda, J., Levy, B.D., The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J. Immunol. 184 (2010), 836–843.
154. Serhan, C.N., The resolution of inflammation: the devil in the flask and in the details. FASEB J. 25 (2011), 1441–1448.
155. Serhan, C.N., Pro-resolving lipid mediators are leads for resolution physiology. Nature 510:7503 (2014), 92–101.
156. Serhan, C.N., Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB J., Jan 13, 2017, 10.1096/fj.201601222R.
157. Serhan, C.N., Brain, S.D., Buckley, C.D., Gilroy, D.W., Haslett, C., O'Neill, L.A.J., Perretti, M., Rossi, A.G., Wallace, J.L., Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21 (2007), 325–332.
158. Serhan, C.N., Chiang, N., Resolution phase lipid mediators of inflammation: agonists of resolution. Curr. Opin. Pharmacol. 13 (2013), 632–640.
159. Serhan, C.N., Chiang, N., Dalli, J., The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin. Immunol. 27:3 (2015), 200–215.
160. Serhan, C.N., Clish, C.B., Brannon, J., Colgan, S.P., Chiang, N., Gronert, K., Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192 (2000), 1197–1204.
161. Serhan, C.N., Dalli, J., Colas, R.A., Winkler, J.W., Chiang, N., Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim. Biophys. Acta 1851 (2015), 397–413.
162. Serhan, C.N., Dalli, J., Karamnov, S., Choi, A., Park, C.K., Xu, Z.Z., Ji, R.R., Zhu, M., Petasis, N.A., Macrophage pro-resolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 26 (2012), 1755–1765.
163. Serhan, C.N., Gotlinger, K., Hong, S., Arita, M., Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostagl. Other Lipid Mediat 73 (2004), 155–172.
164. Serhan, C.N., Hong, S., Gronert, K., Colgan, S.P., Devchand, P.R., Mirick, G., Moussignac, R.-L., Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J. Exp. Med. 196 (2002), 1025–1037.
165. Serhan, C.N., Jain, A., Marleau, S., Clish, C., Kantarci, A., Behbehani, B., Colgan, S.P., Stahl, G.L., Merched, A., Petasis, N.A., Chan, L., Van Dyke, T.E., Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J. Immunol. 171 (2003), 6856–6865.
166. Serhan, C.N., Petasis, N.A., Resolvins and protectins in inflammation-resolution. Chem. Rev. 111 (2011), 5922–5943.
167. Serhan, C.N., Savill, J., Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6 (2005), 1191–1197.
168. Serhan, C.N., Yang, R., Martinod, K., Kasuga, K., Pillai, P.S., Porter, T.F., Oh, S.F., Spite, M., Maresins: novel macrophage mediators with potent anti-inflammatory and pro-resolving actions. J. Exp. Med. 206 (2009), 15–23.
169. Shinohara, M., Kibi, M., Riley, I.R., Chiang, N., Dalli, J., Kraft, B.D., Piantadosi, C.A., Choi, A.M., Serhan, C.N., Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1. Am. J. Physiol. Lung Cell Mol. Physiol. 307:10 (2014), L746–L757.
170. Shryock, N., McBerry, C., Salazar Gonzalez, R.M., Janes, S., Costa, F.T., Aliberti, J., Lipoxin A(4) and 15-epi-lipoxin A(4) protect against experimental cerebral malaria by inhibiting IL-12/IFN-gamma in the brain. PLoS One, 8(4), 2013, e61882.
171. Spite, M., Claria, J., Serhan, C.N., Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab. 19 (2013), 21–36.
172. Spite, M., Norling, L.V., Summers, L., Yang, R., Cooper, D., Petasis, N.A., Flower, R.J., Perretti, M., Serhan, C.N., Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461 (2009), 1287–1291.
173. Sun, Y.-P., Oh, S.F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S.P., Petasis, N.A., Serhan, C.N., Resolvin D1 and its aspirin-triggered 17R epimer: stereochemical assignments, anti-inflammatory properties and enzymatic inactivation. J. Biol. Chem. 282 (2007), 9323–9334.
174. 4 analogs. Prostaglandins Leukot. Essent. Fat. Acids 81 (2009), 357–366.
175. Tabas, I., Glass, C.K., Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339:6116 (2013), 166–172.
176. Tang, H., Liu, Y., Yan, C., Petasis, N.A., Serhan, C.N., Gao, H., Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury. J. Immunol. 193:7 (2014), 3769–3778.
177. Tobin, D.M., Roca, F.J., Oh, S.F., McFarland, R., Vickery, T.W., Ray, J.P., Ko, D.C., Zou, Y., Bang, N.D., Chau, T.T., Vary, J.C., Hawn, T.R., Dunstan, S.J., Farrar, J.J., Thwaites, G.E., King, M.C., Serhan, C.N., Ramakrishnan, L., Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148:3 (2012), 434–446.
178. Tungen, J.E., Aursnes, M., Vik, A., Ramon, S., Colas, R., Dalli, J., Serhan, C.N., Hansen, T.V., Synthesis, anti-inflammatory and pro-resolving activities of 22-OH-PD1, a mono-hydroxylated metabolite of protectin D1. J. Nat. Prod. 77 (2014), 2241–2247.
179. Van Dyke, T.E., The management of inflammation in periodontal disease. J. Periodontol. 79:Suppl. l (2008), 1601–1608.
180. Van Dyke, T.E., Serhan, C.N., A novel approach to resolving inflammation. Sci. Am. Oral Whole Body Health, 2006, 42–45.
181. Walker, J., Dichter, E., Lacorte, G., Kerner, D., Spur, B., Rodriguez, A., Yin, K., Lipoxin A4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Shock 36:4 (2011), 410–416.
182. Wang, S.B., Hu, K.M., Seamon, K.J., Mani, V., Chen, Y., Gronert, K., Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the cornea. FASEB J. 26 (2012), 1506–1516.
183. Wang, X., Zhu, M., Hjorth, E., Cortés-Toro, V., Eyjolfsdottir, H., Graff, C., Nennesmo, I., Palmblad, J., Eriksdotter, M., Sambamurti, K., Fitzgerald, J.M., Serhan, C.N., Granholm, A.C., Schultzberg, M., Resolution of inflammation is altered in Alzheimer's disease. Alzheimers Dement. 11 (2015), 40–50 e42.
184. Weiss, G.A., Troxler, H., Klinke, G., Rogler, D., Braegger, C., Hersberger, M., High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health Dis., 12, 2013, 89.
185. Winkler, J.W., Orr, S.K., Dalli, J., Cheng, C.Y., Sanger, J.M., Chiang, N., Petasis, N.A., Serhan, C.N., Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance. Sci. Rep., 6, 2016, 18972.
186. Winyard, P.G., Willoughby, D.A., 2003. Inflammation protocols, in: Walker, J.M. (Ed.), Methods Mol. Biol. Humana, Totowa, NJ, p. 378.
187. Wu, B., Walker, J., Spur, B., Rodriguez, A., Yin, K., Effects of Lipoxin A4 on antimicrobial actions of neutrophils in sepsis. Prostaglandins Leukot. Essent. Fat. Acids 94 (2015), 55–64.
188. Wu, S.H., Chen, X.Q., Liu, B., Wu, H.J., Dong, L., Efficacy and safety of 15(R/S)-methyl-lipoxin A(4) in topical treatment of infantile eczema. Br. J. Dermatol 168 (2013), 172–178.
189. Yang, J., Eiserich, J.P., Cross, C.E., Morrissey, B.M., Hammock, B.D., Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients. Free Radic. Biol. Med. 53:1 (2012), 160–171.
190. Yedgar, S., Krimsky, M., Cohen, Y., Flower, R.J., Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?. Trends Pharmacol. Sci. 28 (2007), 459–464.
191. Zhang, M.J., Sansbury, B.E., Hellmann, J., Baker, J.F., Guo, L., Parmer, C.M., Prenner, J.C., Conklin, D.J., Bhatnagar, A., Creager, M.A., Spite, M., Resolvin D2 enhances postischemic Revascularization while resolving inflammation. Circulation 134:9 (2016), 666–680.
192. Zhu, M., Wang, X., Schultzberg, M., Hjorth, E., Differential regulation of resolution in inflammation induced by amyloid-beta42 and lipopolysaccharides in human microglia. J. Alzheimers Dis. 43:4 (2015), 1237–1250.